Synaptojanin 2 is a druggable mediator of metastasis and the gene is overexpressed and amplified in breast cancer
pmid: 25605973
Synaptojanin 2 is a druggable mediator of metastasis and the gene is overexpressed and amplified in breast cancer
Small-molecule inhibitors of the lipid phosphatase synaptojanin 2 may prevent breast cancer metastasis.
- Bar-Ilan University Israel
- Feinstein Institute for Medical Research United States
- University of Cambridge United Kingdom
- Northwell Health United States
- Tel Aviv University Israel
Immunoblotting, Gene Dosage, Fluorescent Antibody Technique, Breast Neoplasms, Mice, SCID, Immunohistochemistry, Phosphoric Monoester Hydrolases, ErbB Receptors, Gene Expression Regulation, Neoplastic, Mice, Cell Movement, Cell Line, Tumor, Drug Discovery, Podosomes, Image Processing, Computer-Assisted, Microscopy, Electron, Scanning, Animals, Humans, Female, Neoplasm Metastasis
Immunoblotting, Gene Dosage, Fluorescent Antibody Technique, Breast Neoplasms, Mice, SCID, Immunohistochemistry, Phosphoric Monoester Hydrolases, ErbB Receptors, Gene Expression Regulation, Neoplastic, Mice, Cell Movement, Cell Line, Tumor, Drug Discovery, Podosomes, Image Processing, Computer-Assisted, Microscopy, Electron, Scanning, Animals, Humans, Female, Neoplasm Metastasis
4 Research products, page 1 of 1
- 2018IsRelatedTo
- 2018IsRelatedTo
- 2017IsRelatedTo
- 2018IsRelatedTo
citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).57 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Top 10% influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Top 10% impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Top 10%
